lguratimod Impurities

Iguratimod is primarily used in the treatment of rheumatoid arthritis due to its potent anti-inflammatory and immunomodulatory effects. It works by inhibiting pro-inflammatory cytokines like IL-1 and TNF-α, reducing joint inflammation and damage. Maintaining high purity in Iguratimod formulations is crucial for ensuring its therapeutic efficacy and patient safety. Related impurities, if present, can impact the drug’s stability and performance. Therefore, impurity profiling, including identification and quantification, is essential in pharmaceutical research and development. Our impurity control ensures that Iguratimod remains a reliable and effective option for treating autoimmune diseases with minimal risk of adverse effects.